Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-05-04 Purchase | 2021-05-06 4:19 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Innovations Fund GP LLC MPM Oncology Impact Management GP LLC 10% Owner | 245,000 | $16 | $3,920,000 | 6,672,183 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-05-04 Conversion | 2021-05-06 4:19 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Innovations Fund GP LLC MPM Oncology Impact Management GP LLC 10% Owner | 57,683,698 | $0 | 6,672,183 (Indirect) | View |
Ownership | 2021-04-29 5:31 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Innovations Fund GP LLC MPM Oncology Impact Management GP LLC 10% Owner | 0 | $0 | 6,486,087 (Indirect) | View |